WASH3P (Gene)

Entrez:374666

Description:WASP family homolog 3, pseudogene

Predicted to enable alpha-tubulin binding activity. Involved in several processes, including Arp2/3 complex-mediated actin nucleation; early endosome to late endosome transport; and protein targeting to lysosome. Located in endosome; filopodium; and lamellipodium. [provided by Alliance of Genome Resources, Apr 2022]

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View WASH3P's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with WASH3P.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using WASH3P.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for WASH3P.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with WASH3P.

Results found

Linked to

	Label	Description
	GSE193351 ruxolitinib 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE197571 FOXM1 RNF112 overexpression MGC-803 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE60217 adenosine 1 v 9 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE134029 cisplatin 3 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE161897 MBNL knockout 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE68925 fasudil 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE233112 doxorubicin 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE201309 matrine 1 v 8 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE203329 HCC knockout 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE158834 ADIPOR2 knockout HEK293 1 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS

GSE193351 ruxolitinib 1 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE197571 FOXM1 RNF112 overexpression MGC-803 2 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE60217 adenosine 1 v 9 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE134029 cisplatin 3 v 0 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE161897 MBNL knockout 2 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE68925 fasudil 1 v 0 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE233112 doxorubicin 2 v 0 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE201309 matrine 1 v 8 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE203329 HCC knockout 2 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE158834 ADIPOR2 knockout HEK293 1 v 6 human up

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.